WJ
Therapeutic Areas
Haisco Pharmaceutical Group Pipeline
| Drug | Indication | Phase |
|---|---|---|
| HSK7653 | Type 2 Diabetes | Phase III |
| HSK16149 | Neuropathic Pain | Phase III |
| HSK21542 | Pruritus (Chronic Liver Disease) | Phase III |
| HSK401 (Bevacizumab Biosimilar) | Non-small Cell Lung Cancer, Colorectal Cancer | Phase III |
| HSK31858 | Non-Cystic Fibrosis Bronchiectasis | Phase II |
| HSK29116 | B-cell Malignancies | Phase I/II |